NOBILI, ELISABETTA
 Distribuzione geografica
Continente #
NA - Nord America 1.725
EU - Europa 1.162
AS - Asia 685
AF - Africa 95
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
SA - Sud America 1
Totale 3.673
Nazione #
US - Stati Uniti d'America 1.720
GB - Regno Unito 350
CN - Cina 227
VN - Vietnam 202
SE - Svezia 180
SG - Singapore 159
IT - Italia 133
DE - Germania 125
IN - India 70
IE - Irlanda 69
CH - Svizzera 66
RU - Federazione Russa 57
FR - Francia 52
UA - Ucraina 34
TG - Togo 33
ZA - Sudafrica 33
EE - Estonia 29
BG - Bulgaria 26
FI - Finlandia 16
CI - Costa d'Avorio 14
NG - Nigeria 11
BE - Belgio 10
JO - Giordania 10
JP - Giappone 5
CA - Canada 4
IR - Iran 4
EU - Europa 3
GR - Grecia 3
ID - Indonesia 3
RO - Romania 3
SC - Seychelles 3
AU - Australia 2
HR - Croazia 2
LB - Libano 2
NL - Olanda 2
SK - Slovacchia (Repubblica Slovacca) 2
CL - Cile 1
CZ - Repubblica Ceca 1
HU - Ungheria 1
KR - Corea 1
MU - Mauritius 1
MX - Messico 1
PT - Portogallo 1
SA - Arabia Saudita 1
TR - Turchia 1
Totale 3.673
Città #
Southend 327
Chandler 214
Fairfield 155
Singapore 145
Ashburn 142
Dong Ket 112
Wilmington 91
Woodbridge 87
Houston 81
Princeton 80
Santa Clara 76
Seattle 73
Dublin 69
Ann Arbor 68
Bern 63
Boardman 48
Cambridge 39
New York 38
Westminster 34
Lomé 33
Padova 30
Nanjing 28
Sofia 26
Shenyang 23
Turin 22
Medford 21
Beijing 20
Jacksonville 18
Bologna 17
Saint Petersburg 17
Helsinki 16
Hebei 15
Abidjan 14
Changsha 14
San Diego 14
Des Moines 13
Berlin 12
Jinan 12
Abeokuta 11
Amman 10
Brussels 10
Florence 10
Milan 10
Nanchang 10
Falls Church 9
Redwood City 9
Jiaxing 8
Kuban 8
Norwalk 8
Hangzhou 7
Mülheim 7
Shanghai 7
Tianjin 7
Fremont 6
Guangzhou 6
Los Angeles 6
Monmouth Junction 5
Taiyuan 5
Zhengzhou 5
Bremen 4
Bühl 4
Castelfranco Emilia 4
Kunming 4
Lanzhou 4
Olalla 4
Shenzhen 4
Taizhou 4
Haikou 3
Jakarta 3
London 3
Mahé 3
Mountain View 3
Paris 3
Pune 3
Rome 3
San Venanzo 3
Toronto 3
Xi'an 3
Brunswick 2
Dearborn 2
Duncan 2
Frankfurt Am Main 2
Fuzhou 2
Kilburn 2
Kumar 2
Lausanne 2
Leawood 2
Manfredonia 2
Ningbo 2
Phoenix 2
Romainville 2
Ružomberok 2
Verona 2
Altamira 1
Ardabil 1
Bo 1
Bolzano 1
Brescia 1
Budapest 1
Chengdu 1
Totale 2.573
Nome #
A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. 177
Autoimmune pancreatitis associated with high levels of chromogranin a, serotonin and 5-hydroxyindoleacetic Acid 164
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. 150
Clinical management of a pituitary gland metastasis from clear cell renal cell carcinoma. 144
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 136
Breast carcinoma presenting as linitis plastica 130
Spontaneous regression of a desmoid intraabdominal tumor in a patient affected by familial adenomatous polyposis. 122
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? 120
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 118
Impact of surgery on the development of duodenal cancer in patients with familial adenomatous polyposis. 113
High prevalence of asbestos exposure in bile duct cancer patients 112
Capecitabine(CAP) based regimens vs infusional 5FU/AF in metastatic colorectal cancer cost/effectivness: the differences across the atlantic ocean 111
Impact of adjuvant chemotherapy on time to relapse in cholangiocarcinoma. 109
Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study. 108
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? 106
Effect of the serine proteases inhibitor gabexate mesylate (GM) on the activity of gemcitabine (G) in cell lines of pancreatic cancer (PC) 105
KRAS and BRAF mutational status as selective criteria for targeted therapy in cholangiocarcinoma. 103
EXOCRINE-ENDOCRINE PANCREATIC CANCER AND alpha-FETOPROTEIN 100
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 99
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? 99
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 99
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 93
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE 92
Nanotechnology-Related environment, health and safety Research 91
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients 88
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOISTITUTIONAL EXPERIENCE. 85
TO WIDEN THE SETTING OF CANCER PATIENTS WHO BENEFIT FROM METRONOMIC CAPECITABINE 84
Systemic adjuvant chemotherapy after resection of colorectal cancer metastases 81
IMPACT OF MULTIDISCIPLINARY APPROACH ON SURVIVAL OF PATIENTS WITH KLATSKIN TUMOR 79
METRONOMIC CAPECITABINE IN HEPATOCELLULAR CARCINOMA RELAPSE AFTER LIVER TRANSPLANTATION: A RETROSPECTIVE STUDY 77
THE RISK OF DUODENAL CANCER IN FAMILIAL ADENOMATOUS POLYPOSIS (FAP) 77
The protease inhibitor gabexate Mesylate has antitumor effects and enhances gemcitabine action on pancreatic cancer cell lines 70
Single-agent carboplatin in extensive disease small-cell lung cancer patient with liver failure: A case report within the experience of a single institution 70
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma 68
Hyperammonemic encephalopathy during XELOX regimen. Is it capecitabine or oxaliplatin responsible? 66
Critical diagnostic delay associated with unusual presentation of hepatocellular carcinoma (Hcc) with orbital metastases: A case report 65
PATINUM-BASED CHEMOTHERAPY FOR THE TREATMENT OF HIGH-GRADE GASTROINTESTINAL AND UNKNOWN PRIMARY NEUROENDOCRINE NEOPLASMS 53
Improving IMDC Prognostic Prediction Through Evaluation of Initial Site of Metastasis in Patients With Metastatic Renal Cell Carcinoma 8
Totale 3.772
Categoria #
all - tutte 9.734
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.734


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020505 0 0 0 0 65 60 80 87 84 41 38 50
2020/2021485 92 16 16 7 2 30 5 12 55 18 11 221
2021/2022737 64 28 26 55 59 42 13 45 44 63 180 118
2022/2023883 85 114 35 100 53 64 25 51 142 40 89 85
2023/2024246 18 28 12 27 19 83 14 22 4 10 4 5
2024/2025389 17 107 72 66 127 0 0 0 0 0 0 0
Totale 3.772